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Abstract
Background: chicken meat extract is a popular functional food in Asia. It is rich in the bioactive compounds
carnosine and anserine, two histidine-containing dipeptides (HCD). Studies suggest that acute pre-exercise
ingestion of chicken extracts has important applications towards exercise performance and fatigue control, but the
evidence is equivocal. This study aimed to evaluate the ergogenic potential of the pre-exercise ingestion of a
homemade chicken broth (CB) vs a placebo soup on a short-lasting, high-intensity cycling exercise.
Methods: fourteen men participated in this double-blind, placebo-controlled, crossover intervention study. Subjects
ingested either CB, thereby receiving 46.4mg/kg body weight of HCD, or a placebo soup (similar in taste without HCD)
40min before an 8min cycling time trial (TT) was performed. Venous blood samples were collected at arrival (fasted),
before exercise and at 5min recovery. Plasma HCD were measured with UPLC-MS/MS and glutathione (in red blood cells)
was measured through HPLC. Capillary blood samples were collected at different timepoints before and after exercise.
Results: a significant improvement (p = 0.033; 5.2%) of the 8min TT mean power was observed after CB supplementation
compared to placebo. Post-exercise plasma carnosine (p < 0.05) and anserine (p < 0.001) was significantly increased after
CB supplementation and not following placebo. No significant effect of CB supplementation was observed either on
blood glutathione levels, nor on capillary blood analysis.
Conclusions: oral CB supplementation improved the 8min TT performance albeit it did not affect the acid-base balance
or oxidative status parameters. Further research should unravel the potential role and mechanisms of HCD, present in CB,
in this ergogenic approach.
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Background
Chicken meat and its extracts have long been recognized
as a source of bioactive molecules that can potentially
improve health status in general, and exercise perform-
ance in particular. In traditional South-Asian medicine,
chicken extracts are used to alleviate stress or mild dis-
ease symptoms [1]. The activities of chicken extracts are
suggested to be related to its active components, includ-
ing proteins, free amino acids, taurine, many minerals,
trace elements, and vitamins. In addition, chicken meat
extracts contain high concentrations of carnosine (β-al-
anyl-L-histidine) and anserine (β-alanyl-π-methyl-histi-
dine) in a 1:2 to 1:3 ratio [2, 3].
Carnosine and its methylated analogue anserine are
histidine-containing dipeptides (HCD) present in high
concentrations in skeletal muscle of mammals and
therefore abundantly present in the daily food of non-
vegetarian persons [2]. Harris et al. [4] demonstrated
that long-term administration of β-alanine - one of the
constituent amino acids - is able to raise muscle carnosine
concentrations, which leads to enhanced high-intensity
exercise performance [5, 6]. The chronic use of chicken
breast extract, containing carnosine and anserine, is
shown to enhance muscle carnosine levels in humans [7]
and to improve high-intensity endurance performance by
attenuation of muscle fatigue [8], demonstrating the same
mechanism of action of the β-alanine supplementation
approach.
In contrast to chronic supplementation strategies, aim-
ing to promote muscle carnosine loading (thus increas-
ing the intracellular muscle pH-buffer capacity), it can
be hypothesized that acute supplementation, leading to
elevated circulating HCD, may exert ergogenic effects
through attenuation of acidosis and/or oxidative stress
in blood. Unfortunately, the bioavailability of carnosine
in the circulation following supplementation is very low
in humans due to the fast breakdown by the very active
human serum carnosinase-1 (CN1) enzyme, and acute
carnosine supplementation (20 mg/kg BW) could not
elicit improvements in a high-intensity cycling test [9].
Interestingly, both in vitro [3, 10, 11] and in vivo [12, 13]
experiments revealed that anserine is much less prone to
hydrolysis by carnosinase due to the lower affinity to the
CN1 enzyme, suggesting that anserine or a combination of
anserine plus carnosine might be required to induce acute
ergogenic effects. A recent study of Blancquaert et al. (un-
published, congress presentation: http://hdl.handle.net/1
854/LU-8642579) demonstrated increased HCD stability in
the circulation by a combination of pure (chemically
synthesized) carnosine and anserine ingestion in a 1:1 ratio
(25mg/kg BW of each) compared to anserine alone (25
mg/kg BW). In addition, performance-enhancing effects of
this pre-exercise supplementation strategy were found on
maximal Wingate power in healthy humans.
The ergogenic potential of acute pre-exercise supple-
mentation of chicken extracts (containing both carno-
sine and anserine) is already tested by Suzuki and
colleagues, but the results are so far inconclusive. Suzuki
et al. [14] showed that the pre-exercise intake of the
chicken breast extract (denominated as CBEX™), con-
taining 0.4 g carnosine and 1.1 g anserine, enhanced the
power output of the latter half of 2 sets of repeated
sprints. In a follow-up study using the same supplemen-
tation strategy for a single set of similar repeated sprints,
no improvement on performance was found, although a
positive effect on exercise-induced acid-base balance was
present [15].
Informed by this emerging evidence for an acute effect
of pre-exercise supplementation of pure HCD on exer-
cise performance, we evaluated the effect of a similar
dose of HCD in a functional food approach, i.e. through
a home-prepared chicken broth (CB) vs a placebo soup
(PLA), in a cross-over nutritional intervention study.
The purpose of this study is to examine the ergogenic
effect of the chicken broth (CB), according to the recipe
from Harris et al. [4], administered as a 40-min pre-
exercise snack, on a short-lasting, high-intensity cycling
exercise (8 min cycling time-trial). The type and duration
of the exercise were aimed to challenge the possible er-
gogenic effects of anserine and carnosine in the CB
based on their contribution to the intracellular acid-base
balance as well as oxidative stress control [16, 17].
Methods
Study design
Twenty healthy, recreationally-trained men voluntarily
participated in this double-blind, placebo-controlled,
crossover, nutritional intervention study. The partici-
pants attended the Aspire Academy Sport Science
Laboratory (Doha, Qatar) on five separate occasions.
During the first session a maximal incremental oxygen
uptake test (VO2max) was performed on a cycling
ergometer. The second and third visits were reserved for
familiarization of the cycling time trial (TT) protocol,
consisting of 10 min warm up and 8min TT. Supple-
mentation conditions (CB or placebo soup) were per-
formed once each, in a random order, on visit 4 and 5
with 1 week time in between. Allocation to the CB and
placebo condition was done by an independent researchers,
thereby guaranteeing that both subjects and investigators
were blinded for the condition. Figure 1 illustrates the time
schedule of visits four and five.
Subjects
Participants underwent a routine medical assessment by
a medical doctor and an evaluation of their body mass
index (BMI), age and lifestyle was done in the laboratory.
A questionnaire was asked for the training rate, food
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habits, sleeping hours and lifestyle habits. Subject were
used to train ~ 10 h/week on average (mixed: swimming-
cycling-running-strength). Before the start of the study,
a training log was taken and we performed a direct as-
sessment of training status via VO2max test. The defin-
ition “recreationally-trained” was given after evaluation
of the VO2max test results (< 55mL/kg/min, except for
2 participants who were above that value). A food log
was required to any participant for the whole duration
of the study. Subjects were instructed to maintain their
normal dietary habits except for the last meal before the
test days where a vegetarian meal was proposed as the
only alternative, not to bias the upcoming results on
carnosine, anserine on the following day.
Inclusion criteria were males, non-vegetarian, not tak-
ing any drugs and/or food supplements 3 month prior
and during the study period, medium-high weekly train-
ing habits. During the course of the study, 6 subjects
dropped out (2 got sick, one relocated to another Coun-
try, one for an ankle injury, 2 for work reasons). Of the
fourteen subjects that completed the study, subjects’ age,
weight and relative maximal oxygen consumption were
37.2 ± 6.5 years, 76.2 ± 10.0 kg and 50.0 ± 5.5 mL/min/kg,
respectively. They gave their written informed consent
and the Local Ethical Committee (Anti-Doping Labora-
tory Qatar, ADLQ) approved the study.
VO2max test
The maximal incremental oxygen uptake test (VO2max)
was performed on a cycling ergometer (SRM bike;
Schoberer Rad Messtechnik, Germany) using the Oxy-
con Pro ergospirometry testing device (Cardinal Health
Germany 234 GmbH Leibnizstrasse 7, Hoechberg,
Germany). Throughout this cycling test, starting at 100
W for 2 min and with an incremental rate of 50W/2
min, the subjects maintained a constant pedal cadence
of 80 rpm until volitional exhaustion. Maximal oxygen
uptake (VO2max) was identified through breath-by-
breath gas exchange analysis.
Supplementation
Subjects were instructed to follow a vegetarian meal
(thus free of HCDs) on the evening before the test day
and to observe 12 h fasting before their arrival. Once in
the laboratory, participants were questioned about the
compliance of the dinner meal instruction and once
assessed it, they received a HCD-free pre-trial meal, de-
signed with standardized nutritional recommendations
to help optimize performance during short-term, high
intensity exercise (1.5 g/kg BW carbohydrate intake:
white bread, jam, Nutella, butter and Gatorade). They
ate their breakfast in a separate room. Two hours after
their breakfast and 25min prior to warm-up, subjects
consumed 8mL/kg BW of CB, thereby administering
46.4 mg/kg BW of HCD, or placebo soup similar in taste
but without HCD (vegan soup, flavoured with chicken
flavour stock powder from InaPaarman’s). CB intake was
scheduled 25min before the start of the exercise
sequence (warm up + time trial) based on Everaert et al.
[12] who found peak plasma anserine concentrations be-
tween 24 and 31min following intake of nutritionally
relevant doses of synthesized anserine. Subjects were
allowed to drink water ad libitum throughout the experi-
ment. One person accidentally received CB on both
occasions, as clearly appeared from the plasma HCD
analysis. This subject was therefore excluded from all
analysis, resulting in a trial group of 13 subjects.
Time trial
The test was performed using the same SRM cycling
ergometer as in the maximal incremental oxygen uptake
test. The 10min warm-up for the 8min TT consisted of
Fig. 1 Time schedule of the actual test days (visit 4 and 5)
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the following sequence: 3 min at 100W, 3 min at 150W,
3 min at 200W, 15 s at 60W, 15 s at 350W sprint, 15 s
at 60W, 15 s at 350W sprint. Following 5 min of rest,
the 8 min TT was started, during which subjects were
free to choose cadence and speed. Subjects received
feedback only on the time using a stopwatch, whilst
power and cadence were blind during the TT. Bike was
set in a linear mode and the mean power during 8 min
(expressed as W/kg) was the primary performance out-
come measure. Percentage change between the two con-
ditions was calculated. The performance outcome was
checked for order effects. Overall, 7 subjects performed
best on the first testday, 5 subjects performed best on
the second testday, and 1 subject performed equally well
on both testdays, assuring that no order effects were
present.
Preparation of CB and placebo soup
The experimental chicken broth was prepared according
to Harris et al. [4] with minor modifications. Fresh
chicken breast meat was retrieved from a local international
food store (Doha, Qatar), with the meat originating from
The Netherlands (Europe). Chicken breast (skinned and
boned) was finely chopped and boiled for 25min with
water (1 l for every 1.5 kg of chicken). Residual chicken
meat was removed by course filtration. The filtrate was fla-
voured by the addition of carrot, onion, celery, salt, pepper,
basil, parsley and tomato puree, and re-boiled for a further
20min and then cooled before final filtration through fine
muslin at 4 °C. The yield from 1.5 kg chicken in 1 l of water
was 870mL of stock. Placebo soup was prepared using the
same flavouring agents and vegetables in boiling water,
without adding any meat. Single portions of both CB and
placebo soup were prepared according to any participant’s
body weight (8mLmL/kg BW) and frozen in plastic bottles
at − 80 °C until consumption. Each bottle was placed in a
closed freezing bag for hygienic conditions. Only the freez-
ing bags containing the bottles were labelled in order to
guarantee double-blinding during the test days.
HCD in CB and placebo soup
Carnosine and anserine levels were quantified in both
CB and placebo soup preparations through HPLC-
fluorescence on two representative samples of each soup,
following the method described by Everaert et al. [18].
The carnosine and anserine concentrations of the CB
were 8.61 and 16.05 mmol/L respectively and found
below the limit of detection in the placebo soup. The
subjects thus consumed 1181 ± 156 mg carnosine (15.6
mg/kg BW), 2340 ± 308 mg anserine (30.8 mg/kg BW),
totalling 3522 ± 464 mg of HCD (46.4 mg/kg BW) in a
portion of 607 ± 80mL chicken broth (8 mL/kg BW).
Blood gas parameters
Capillary blood samples (70 μL) were taken by finger
pricking and analysed with a blood gas analyzer (ABL90
Flex; Radiometer, Brønshøj, Denmark) at five different
time points: fasted (at arrival), before warm-up, follow-
ing 8 min TT, after 5 min and 10min recovery. The
samples were analysed for glucose, pH, lactate, bicarbon-
ate and electrolytes (K+, Ca2+, Cl− and Na+).
Plasma HCD levels
Venous blood samples (EDTA) were collected at three
time points: fasted, pre-exercise and 5min post-exercise
recovery. Precooled (4 °C) EDTA tubes were centrifuged
immediately after blood collection at 4 °C to separate
plasma. Plasma samples were deproteinized with 35%
sulfosalicylic acid (SSA) and stored immediately at −
20 °C until analysis. These samples were analysed for
plasma carnosine and anserine by an in-house developed
and validated UPLC-MS/MS method. The analytical
standards of L-carnosine and L-anserine were chemically
synthesized by Flamma S.p.a. (Chignolo d’Isola, Bergamo,
Italy). The internal standard (IS), carnosine-D4, was
purchased from Sanbio B.V. (Uden, The Netherlands).
Acetonitrile (ACN), methanol and formic acid (FA) were
ULC-MS grade and obtained from Biosolve (Valkens-
waard, The Netherlands). A Milli-Q® water system (Merck
Millipore, Darmstadt, Germany) was used to obtain ultra-
pure water. Deproteinized plasma was vortexed and
150 μL was added to 240 μL of methanol containing 1%
formic acid and 10 μL IS (2.5 μM in water). Samples were
vortexed (30 s) before centrifugation (15min, 4 °C, 15000
g) and 350 μL of supernatant was evaporated (35 °C, vac-
uum, Gyrovap). The remaining droplet of about 20 μL was
redissolved in 90 μL ultrapure water and vortexed for 30 s
before being transferred to an autosampler vial (Filterser-
vice, Eupen, Belgium). A 5 μL aliquot was injected onto
the UPLC-MS/MS system.
Analyses were performed on an UPLC-MS/MS
platform consisting of an Acquity H-Class Quaternary
Solvent Manager and Flow-Through-Needle Sample
Manager with temperature controlled tray (8 °C) and
column oven (45 °C), all from Waters (Milford, MA,
USA). Chromatographic separation was achieved on an
Acquity UPLC HSS T3 column (100 × 2.1 mm, dp:
1.8 μm, Waters) in combination with an Acquity HSS T3
1.8 μm Vanguard pre-column, both from Waters. Gradi-
ent elution was established with a mobile phase consist-
ing of 0.1% (v/v) FA in water (solvent A) and 0.1% (v/v)
FA in ACN (solvent B) at a flow rate of 0.4 mL/min. The
following gradient was used: 0.0–1.5 min (99% A, 1% B),
1.5–2.0 min (linear gradient to 5% A, 95% B), 2.0–3.5
min (5% A, 95% B), 3.5–4.0 min (linear gradient to 99%
A, 1% B), 4.0–7.0 min (99% A, 1% B). The UPLC column
effluent was interfaced to a Xevo TQ-XS® MS/MS
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system, equipped with an electrospray ionization (ESI)
probe operating in the positive mode (all from Waters).
A divert valve was used and the UPLC effluent was
directed to the mass spectrometer from 0.2 to 3.0 min.
Instrument parameters were optimised by direct infusion
of working solutions of 100 ng/mL of carnosine, anserine
and the IS, respectively, at a flow-rate of 10 μL/min and
in combination with the mobile phase (50% A, 50% B,
flow-rate: 200 μL/min). The settings on the Xevo TQ-
XS® were as follows: desolvation gas flow rate: 800 L/h;
desolvation temperature: 500 °C; cone gas flow rate: 150
L/h; source temperature: 150 °C. The capillary voltage
was optimized at 3.00 kV for ESI in positive ionization
mode. The detector was operating in multiple reacting
monitoring mode, scanning the two most intense transi-
tions of carnosine: m/z 227.2 > 110.1 (quantification ion,
cone = 35 V; collision energy (CE) = 20 eV) and m/z
227.2 > 156.1 (confirmation ion, cone = 35 V; CE = 13 eV),
anserine: m/z 241.2 > 109.1 (quantification ion, cone = 30
V; CE = 23 eV) and m/z 241.2 > 170.1 (confirmation ion,
cone = 30 V; CE = 15 eV) and carnosine-D4 (IS): m/z
231.0 > 110.1 (quantification ion, cone = 30 V; CE = 22 eV)
and m/z 231.0 > 156.0 (confirmation ion, cone = 30 V;
CE = 15 eV). Masslynx software 4.2 (Waters) was used for
instrument control and data extraction.
Pooled EDTA plasma used to prepare the calibration
curve and quality control samples was obtained from 2
healthy volunteers who followed a lacto-ovo-vegetarian
diet free of HCD for 2 days prior to blood withdrawal.
This plasma pool contained basal carnosine and anserine
concentrations of 23.34 ± 2.78 nmol/L and 7.93 ± 4.40
nmol/L, respectively. For quantification, a 10-point cali-
bration curve was prepared by spiking aliquots of the
pooled deproteinized EDTA plasma with known concen-
trations of carnosine and anserine ranging between 5
and 15,000 nmol/L. Calibration curves showed good lin-
earity (r > 0.99 and goodness-of-fit coefficient < 20%,
Table 1). Quality control (QC) was performed by spiking
pooled plasma with 50, 500 and 5000 nmol/L of the
dipeptides. The results of these QC samples could also
be used to evaluate the within-run and between-run
precision of the LC-MS/MS method, which fell within
the acceptance ranges (Table 2). Calculated limit of de-
tection (LOD) values were 5.72 nmol/L and 10.61 nmol/
L for carnosine and anserine, respectively (Table 1). No
carry-over of the analytes of interest was observed on
the UPLC-MS/MS instrument. Results are expressed as
absolute concentrations and the change in carnosine and
anserine concentrations in blood due to supplement in-
take was calculated by subtracting baseline values from
the 5 min recovery values.
Glutathione levels
Heparin venous blood samples to determine glutathione
levels were collected at arrival (fasted), before warm-up
and following exercise. Heparinized blood was treated
with BPDS (bathophenanthrolinedisulfonic acid diso-
dium salt hydrate solution) 1 mM and after centrifuga-
tion, 300 μL red blood cells (RBC) were stored at − 20 °C
until further analysis. Quantification of reduced and oxi-
dized glutathione forms (GSH and GSSG, respectively)
was based on methods previously described by Reed
et al. [20] and Yoshida [21]. In short, the derivatization
procedure includes the reaction of iodoacetic acid with
thiols to form S-carboxymethyl derivatives followed by
chromophore derivatization of primary amines with San-
ger’s reagent, 2,4-dinitrofluorobenzene at pH 8–9 over-
night at 4 °C. Samples were centrifuged, filtered
(cellulose syringe filter of 0.20 μm) and transferred to a
HPLC vial. Derivatives were separated on a 3-
aminopropyl column (EC250/4.6 Nucleosil 120–7 NH2;
C18 4.6 × 150 mm, 5 μm) by reversed-phase ion-
exchange HPLC (Agilent 1200 series). The separation
was carried out at 1.50 mL/min and 40 °C. The eluted
derivatives were measured by detection at 365 nm (DAD
detector). GSH and GSSG were identified by retention
times of authentic internal and external standards.
Plasma CN1 activity
CN1 activity was determined on heparinized plasma
from the fasted state of the placebo supplementation test
day, according to the method described by Teufel et al.
[22]. Briefly, the reaction was initiated by addition of
substrate (L-carnosine) to a heparinized plasma sample
and stopped after 10 min of incubation at 37 °C by add-
ing 1% sulfosalicylic acid (SSA). Liberated histidine was
derivatized with o-phthaldialdehyde, and the maximum
increase was used for determining the maximum activity.
Fluorescence was measured by excitation at 360 nm and
emission at 460 nm.
Table 1 Results of the evaluation of linearity (slope (a), intercept (b), goodness-of-fit coefficient (g), correlation coefficient (r)), limit of
quantification (LOQ), limit of detection (LOD) for the LC-MS/MS analysis of carnosine (CAR) and anserine (ANS) in human plasma






CAR 5–10,000 0.035 ± 0.046 0.202 ± 0.017 8.5 ± 0.7 0.9961 ± 0.0006 50 5.7
ANS 5–10,000 0.006 ± 0.000 0.044 ± 0.021 6.0 ± 2.2 0.9978 ± 0.0015 50 10.6
Note: acceptance criteria: r ≥ 0.99, g ≤ 20%; aLOD = 3 x Sres/a with Sres = residual standard deviation (corresponding with the standard deviation of the intercept (b)
of minimal 3 calibration curves) and a = slope
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Statistics
A paired T-test was used to evaluate the effect of CB or
placebo ingestion on mean power output of the 8min TT.
A 2 × 3 repeated measures analysis of variance ANOVA
was used to evaluate plasma carnosine and anserine levels
and glutathione levels in RBC with condition (CB or pla-
cebo) and time (fasted, pre-exercise and 5min recovery)
as within factors. A 2 × 5 repeated-measures ANOVA was
used to evaluate glucose, pH, lactate, bicarbonate and
electrolytes with condition (CB or placebo) and time
(fasted, pre-exercise, post-exercise, 5 min recovery, 10min
recovery) as within factors. In case of a significant inter-
action, a Tukey post hoc analysis was performed. In case
of missing values, a mixed-effects analysis was used. Cor-
relations between CN1 activity and performance output
were obtained by means of Pearson correlations. All statis-
tical analyses were performed with Graphpad Prism ver-
sion 8.0. Values are presented as mean ± SD and statistical
significance threshold was set at p ≤ 0.05.
Results
Exercise performance
A significant difference (p = 0.033, t = 2.406) was ob-
served between the CB and placebo (PLA) supplemented
conditions for mean power during the 8 min TT (Fig. 2).
Mean relative power output was 5.2% higher following
CB supplementation compared to placebo (5.0W/kg ±
0.7 vs 4.75W/kg ± 0.7, respectively).
Plasma HCD values
The results of the in-house validation of the LC-MS/MS
method that was used to quantitate carnosine and anserine
Table 2 Results of the within-run and between-run precision and accuracy evaluation for the analysis of carnosine (CAR) and
anserine (ANS) in plasma using LC-MS/MS
Component Theoretical concentration (nM) Mean concentration ± SD (nM) Precision, RSD (%) Accuracy (%)
CAR 50 a 54.7 ± 2.3 4.2 9.4
50 b 54.4 ± 2.0 3.7 8.7
500 a 487.5 ± 20.0 4.1 −2.5
500 b 491.8 ± 17.1 3.5 −1.6
5000 4328.1 ± 190.7 4.4 − 13.4
5000 b 4419.0 ± 257.1 5.8 −11.6
ANS 50 a 53.8 ± 2.4 4.4 7.6
50 b 53.3 ± 2.4 4.6 6.6
500 a 483.7 ± 21.2 4.4 −3.3
500 b 499.1 ± 25.8 5.2 −0.2
5000 4307.6 ± 116.6 2.7 −13.8
5000 b 4509.2 ± 322.1 7.1 −9.8
Concentrations of 50, 500 and 500 nM correspond with 11.3, 113.1 and 1131.2 ngmL− 1 of CAR and 12.0, 120.1 and 1201.3 ngmL− 1 of ANS, respectively;
acceptance criteria: accuracy: ≥ 10 to < 100 ngmL− 1: − 30 to + 10%, ≥ 100 ngmL− 1: − 20 to + 10%, within-run precision (RSDmax): ≥ 10 to < 100 ngmL
− 1: 15.0%, ≥
100 ngmL− 1: 10%; between-run precision: ≥ 10 to < 100 ngmL− 1: 23%, ≥100 ngmL− 1: 16% [19].
Note: a Within-run accuracy and precision (n = 6); b Between-run accuracy and precision (n ≥ 3 per day, at least 3 analysis days); SD Standard deviation, RSD
Relative standard deviation
Fig. 2 Mean relative power output (Watt/kg) of the 8min TT following
Placebo (PLA) or Chicken Broth (CB) supplementation. Bars represent
the mean, lines represent individual values (N = 13). * p = 0.033
Barbaresi et al. Journal of the International Society of Sports Nutrition           (2021) 18:15 Page 6 of 12
in plasma are shown in Table 1 (linearity, limit of quantifi-
cation or LOQ and limit of dectection or LOD) and Table
2 (within-run and between-run accuracy and precision),
respectively. As can be seen, all results fell within the
acceptance ranges as recommended by international guide-
lines [19], indicating that the method was fit-for-purpose.
Figure 3 shows the concentrations of plasma carnosine (A)
and anserine (B) both in a fasted state, pre-exercise (25min
after supplementation) and after 5min recovery post-
exercise (53min after supplementation), following either
placebo or CB supplementation. Both plasma carnosine
and anserine demonstrate low concentrations in the nano-
molar range in a fasted state (range plasma carnosine: 17–
30 nmol/L; range plasma anserine: 2–17 nmol/L). A signifi-
cant interaction effect was present for both plasma carno-
sine (p = 0.011, F = 5.573) and anserine (p < 0.001, F =
21.48). Plasma carnosine and anserine did not significantly
change over time following placebo supplementation, while
both metabolites are gradually and highly elevated following
CB ingestion. Significantly higher plasma carnosine and an-
serine levels are found at 5min recovery post-exercise (53
min after supplementation) compared to fasted samples
and pre-exercise samples (25min after supplementation).
Interestingly, plasma anserine at 5min recovery post-
exercise is 50 times higher compared to plasma carnosine
(20,424.7 nmol/L vs 372.7 nmol/L, respectively).
Correlations
A significant negative correlation (r = − 0.692; p = 0.011)
was observed between the CN1 activity and the change
in plasma anserine from the fasted to 5 min recovery
time point (delta) in the CB supplementation condition,
demonstrating that higher CN1 activity attenuates
accumulation of plasma anserine following CB ingestion.
No significant correlations were found between CN1
activity and change in plasma carnosine at these time
points (PLA: r = − 0.333; p = 0.266; CB: r = − 0.311; p =
0.302). However, following CB supplementation, the
change in plasma carnosine was significantly correlated
to the change in plasma anserine (r = 0.790; p = 0.001),
demonstrating that the accumulation of both com-
pounds in plasma is interrelated.
No significant correlation between CN1 activity and
percent improvement in mean power (CB vs. placebo)
was seen (r = 0.237; p = 0.436). Furthermore, no signifi-
cant correlation (r = − 0.102, p = 0.740) was found be-
tween the change in plasma anserine levels and percent
improvement in mean power (CB vs placebo).
Glutathione status
No significant interaction effect was observed for blood
glutathione values (measured in red blood cells (RBC)),
neither for the reduced form (GSH, p = 0.771, F =
0.2620, Fig. 4a), nor for the oxidized one (glutathione di-
sulphide or GSSG, p = 0.267, F = 1358, Fig. 4b). Further-
more, no main effect of time or supplement was present,
suggesting glutathione status is not affected by CB
supplementation.
Capillary blood analysis
Among all the parameters covered by the capillary blood
analysis (pH, lactate, bicarbonate, glucose and electro-
lytes such as Ca2+, Cl− and Na+), no significant inter-
action effect was observed, except for K+ (see Table 3).
However, no significant difference was found for K+
values between conditions at any of the time points. The
Fig. 3 Plasma carnosine (a) and anserine (b) concentrations following either Placebo or Chicken Broth (CB) supplementation. Samples were
collected in a fasted state, pre-exercise (25 min after supplementation) and after 5 min recovery post-exercise (53 min after supplementation).
Values are means ± SD (N = 13); * p < 0.05; ** p < 0.001 significant difference between time points
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difference in pre-exercise to post-exercise K+ values
demonstrate a slightly higher increase following placebo
ingestion compared to CB (1.13 vs 0.55 mmol/L, respect-
ively), but this did not reach statistical significance. Fur-
thermore, all the above-mentioned parameters, except
Cl−, showed a significant time effect, demonstrating that
the exercise affects these parameters independently of
condition.
Discussion
The present study demonstrates that acute pre-exercise
chicken broth (CB) ingestion significantly increased
plasma concentrations of both carnosine and anserine.
In support of our hypothesis, we report an increase in
mean power during an 8-min cycling time-trial, com-
pared to a vegetarian placebo soup. The ergogenic effect
of acute pre-exercise chicken breast extract (CBEX) in-
gestion was previously explored in two Japanese studies,
but with conflicting conclusions. While Suzuki et al. [14]
showed that the pre-exercise intake of a chicken breast
extract enhanced the power output of the latter half of 2
sets of short maximal repeated sprints, their follow-up
study could not confirm this [15]. The current study
demonstrates a sizeable performance improvement of
5% by pre-exercise chicken broth ingestion in a sports-
relevant type of high-intensity exercise.
The main difference between the experimental (CB)
and the placebo soup was the presence of extracted
chicken meat compounds in the former. Although in
theory many molecules could potentially be responsible
for the ergogenic effect, there is a body of evidence
suggesting that the HCDs, carnosine and anserine, play a
pivotal role. First, the HCDs are the most abundant
organic compounds in the chicken broth and account
for approximately 10% of its dry mass (unpublished data
from our lab). More importantly, we recently presented
performance-enhancing effects of the pre-exercise
ingestion of a mixture of pure (chemically synthesized)
carnosine and anserine on maximal Wingate power in
humans (Blancquaert et al., congress presentation:
http://hdl.handle.net/1854/LU-8642579). Although the
type of exercise was not identical, the approach (oral
supplementation 30–40 min prior exercise) and dose
(40 mg/kg HCD, ratio 1:1 carnosine:anserine) were very
similar. It remains to be determined whether the find-
ings from the pure supplement powder approach of
Blancquaert et al. and the functional food approach from
the current study rely on the same mechanism, i.e. ele-
vating circulating HCD levels prior to intense exercise.
Based on the design of our experiment, we can, however,
not fully rule out the possible involvement of macro-
and micronutrients, other than HCDs, to underly the er-
gogenic effects found in the current paper.
Upon oral ingestion, carnosine is intactly absorbed as
a dipeptide but is then rapidly degraded by serum CN1
into β-alanine and histidine with an elimination half-life
of merely 1 or 2 min [23]. In contrast, anserine degrad-
ation in blood is less efficient than carnosine, due to the
lower affinity to the CN1 enzyme and the anserine half-life
in human serum is in the range of 5–20min [3, 10–12]. In
the current study, CB intake promoted a significant
increase in both plasma carnosine and anserine in the post-
exercise (53min after supplementation) time point com-
pared to the fasted state. In line with the expectations from
the higher CN1 affinity for carnosine compared to anserine,
the increase in plasma carnosine was 50 times lower com-
pared to the increases in plasma anserine, whereas the car-
nosine:anserine ratio in the broth was 1:2. In addition, there
was a negative correlation between the CN1 activity and
the anserine increase in blood (also called “anserinemia”)
Fig. 4 Reduced glutathione (GSH) (a) and oxidized glutathione (GSSG) (b) values in red blood cells for placebo and Chicken Broth (CB) conditions
at three time points. Values are means + SD (N = 13)
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after CB intake, demonstrating that a lower CN1 activity
promotes more accumulation of plasma anserine.
We have previously shown that elite athletes who excel
in short and high-intensity sport disciplines have a lower
serum CN1 activity compared to untrained controls and
to endurance athletes [9]. Given the low intraindividual
variation and the genetic basis for serum CN1 activity,
that finding may have been the result of performance-
related genetic selection [9]. It could be hypothesized
that athletes with a low CN1 activity have higher circu-
lating HCD levels (upon dietary intake of meat or fish)
and therefore an ergogenic advantage for subsequent
high-intensity exercise performance. In the current
study, we found evidence for the former, but not for the
latter, as we observed a correlation between CN1 activity
and plasma HCD levels, but not with performance
improvements. The individual performance data show
(Fig. 2) show improvement in eleven subjects, of which
two subjects seem to have had a markedly larger
improvement. However, this interindividual variation in
responsiveness could not be explained by variation in
CN1 activity.
In search for a potential ergogenic mechanism, the pH
buffering should be explored as the imposed type of
brief cycling TT severely challenges the pH (decline
from 7.4 to 7.2), bicarbonate (from 25 to 12 mmol/L)
and lactate (from 1 to 16 mmol/L) system. The ergo-
genic mechanism of the muscle carnosine loading strat-
egy by chronic β-alanine supplementation is known to
include attenuation of exercise-induced acidosis by im-
proved muscle pH buffering capacity [4, 17]. It was sug-
gested by Suzuki et al. [15] that also acute pre-exercise
carnosine/anserine supplementation (through chicken
breast extract ingestion) can function as an extracellular
pH buffer in the circulation, as they observed a signifi-
cant sparing of blood bicarbonate during repeated
sprints. Also Baguet et al. [9] found a hint for such ac-
tion, as pre-exercise carnosine ingestion mildly elevated
resting bicarbonate levels. Carnosine and anserine have
an ideal pKa (6.72 and 7.01 for the imidazole nitrogen of
carnosine and anserine, respectively [2]), which is super-
ior to that of bicarbonate to serve as a physiological pH
buffer. However, in the current study, clearly no signifi-
cant effects of CB supplementation were observed on
either pH, lactate or bicarbonate. In hindsight, this is not
fully surprising. Despite their ideal pKa, it should be ac-
knowledged that the almost 700-fold increase in plasma
HCD levels (from 30 nmol/L to 20 μmol/L) attained in
this study, does not by far approach the plasma concen-
trations of bicarbonate, which is still a further 1000-fold
higher (25 mmol/L). Also in comparison to the skeletal
muscle carnosine concentrations, which are in the
millimolar range and can increase by 50% or more in
response to chronic β-alanine supplementation, the
currently observed elevation of plasma carnosine and an-
serine is several orders of magnitude lower and likely
too low to be physiologically meaningful to affect acid-
balance during exercise.
After excluding improved pH buffering as a potential
mechanism of action, it could be hypothesized that the
other prominent bio-active property of HCDs is involved,
namely that of an antioxidant. Acute pre-exercise adminis-
tration of the antioxidant N-acetyl-cysteine has been
shown to improve exercise performance in humans [24].
Also carnosine and anserine have been widely investigated
and consensually accepted as powerful antioxidants [2, 25,
26], but it is unclear whether they can be involved in pro-
tection against oxidative stress and fatigue during exercise
in vivo. Chronic β-alanine supplementation has been
shown to reduce a marker of lipid peroxidation (TBARS)
during downhill running in rats [27], but data in humans
on chronic supplementation of β-alanine [28] or acute sup-
plementation of carnosine [9] did not show reduction in
oxidative stress. Recently, one study [29] suggested that
acute pre-exercise anserine supplementation (15mg/kg or
30mg/kg) could alleviate exercise-induced oxidative stress.
However, the methodology of this study is unsubstantial
and results are poorly reported, making it hard to rely on
these conclusions. In the current study, no significant effect
was observed on blood glutathione values in erythrocytes,
neither on the reduced (GSH) nor oxidized (GSSG) form,
suggesting that the ergogenic effect of the CB is not a
result of its antioxidant capacities. As such, the potential
ergogenic mechanism underlying the present findings is
still unclear and warrant further investigation.
As the nutritional intervention merely involved the
ingestion of a carefully prepared bowl of chicken broth,
no adverse symptoms were expected. Indeed, we
reported no side-effects in any of the subjects in the
present study. The ingested HCD dose was twice as high
as in the studies of Suzuki et al. [14, 15]. In the study of
Everaert et al. [18] a pharmacological dose of 60 mg/kg
BW of pure carnosine elicited side-effects like headache
and paraesthesia in 40% of the subjects. These symptoms
are identical to the ones often reported following intake
of high doses of β-alanine [30]. Some recent studies in
our lab (manuscript in preparation) tested supplementa-
tion of combined pure carnosine and anserine, in a dose
of 30 mg/kg BW of each, and did not elicit adverse
symptoms. These results suggest that in contrast to high
doses of pure carnosine, the combined ingestion of
carnosine and anserine – especially when present in a
real food matrix like a broth - can prevent the occur-
rence of side-effects.
The practical implications relate to a novel approach
in the quest for performance improvement in sports. We
supplemented with 8 mL/kg BW of CB, corresponding
with an average value of 3.5 g HCDs or 46.4 mg/kg BW.
Barbaresi et al. Journal of the International Society of Sports Nutrition           (2021) 18:15 Page 10 of 12
This is equivalent to roughly 350-g serving of chicken
breast meat, known to have a HCD content of approxi-
mately 1 g/100 g wet muscle [3, 31, 32]. This is a realistic
amount to incorporate in a pre-competition dietary plan
of athletes, although it seems much more feasible to de-
liver it in a broth than in a real meat serving. A limita-
tion of this study lies in the fact that we cannot fully
determine whether the performance enhancing effect is
attributable to the presence of carnosine and anserine in
the CB, or (partly) by other macro-and micronutrients,
since the placebo and experimental soups were not com-
pletely identical in regard to the latter. More specifically,
the meat-derived experimental soup evidently had a
higher content of protein/peptides/amino acids than the
vegetarian placebo soup, but literature on potential ergo-
genic effects of pre-exercise protein supplementation
have been limited to the potential glycogen-sparing ef-
fect in prolonged exercise [33], which cannot be extrap-
olated to the current brief time-trial. Another limitation
is that we did not study elite athletes but rather moder-
ately trained individuals. For some ergogenic supple-
ments, like beetroot juice/nitrate, the further translation
from discovery to highly trained athletes proved difficult
[34]. It remains to be established to what extent our
findings can be extrapolated to well-trained athletes and
to women, who were not included in the current design.
In addition to sports application, the discovery of the
underlying mechanism may ultimately also lead the way
to more therapeutic applications. Interestingly, the bene-
ficial effects of the ingestion of carnosine and anserine
mixtures are currently investigated and demonstrated
for a number of applications, such as for cognitive func-
tion in elderly [35–38].
Conclusions
Acute pre-exercise chicken broth ingestion significantly
improved the performance of a high-intensity, short-
lasting cycling exercise. Circulating carnosine and anserine
concentrations were markedly elevated but we currently
could not pinpoint improved acid-base balance nor anti-
oxidant function as potential ergogenic mechanisms. The
full extent of the performance spectrum that benefits from
CB supplementation remains to be established.
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